HomeNewscoronavirusCoronavirus lockdown 3.0 | Johnson Controls-Hitachi AC India resumes operations

Coronavirus lockdown 3.0 | Johnson Controls-Hitachi AC India resumes operations

The company has begun production activity at its manufacturing facility in Kadi, Gujarat.

May 04, 2020 / 17:38 IST
Story continues below Advertisement

Air conditioning firm Johnson Controls-Hitachi Air Conditioning India said it has resumed operations at its Gujarat manufacturing facility. Manufacturers have been allowed to begin production in non-hotspot locations as the coronavirus-led (COVID-19) lockdown continues with some relaxations.

Gurmeet Singh, Chairman and Managing Director, Johnson Controls-Hitachi Air Conditioning India said following government guidelines and abiding by the approved list of activities, the company has been able to successfully start its operations with utmost safety measures.

Story continues below Advertisement

“We have fully sanitized and opened our Delhi, Chennai, Ahmedabad, Bhubaneshwar, Jaipur offices today following operational guidelines of 33 percent staff strength. Our Delhi office started with a very thin attendance as many staff members come from other areas around Delhi and movement is still restricted in these areas,” he added.

Also Read: Live updates from COVID-19 in India

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show